Lunai Bioworks Inc. says it has received a Nasdaq decision that it no longer complies with listing requirements, and the company intends to voluntarily delist and deregister its shares. The company says Nasdaq’s determination was communicated to it in a letter dated October 21, 2026.
Across the sources provided, the emphasis is on the same core development: Nasdaq issues a determination of non-compliance, and Lunai Bioworks responds by moving toward a voluntary exit from Nasdaq and deregistration. One outlet frames the story as a plan to delist, while another highlights the formal receipt of Nasdaq’s determination and the company’s intention to voluntarily delist and deregister, anchoring the announcement in specific timeline details (October 21 determination and October 22 public release).